Skip to main content
Log in

Treatment of chronic hepatitis C in young children cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2018 Canadian dollars

Reference

  • Greenaway E, et al. Treatment of Chronic Hepatitis C in Young Children Reduces Adverse Outcomes and Is Cost-Effective Compared to Deferring Treatment to Adulthood. Journal of Pediatrics : 2 Sep 2020. Available from: URL: http://doi.org/10.1016/j.jpeds.2020.08.088

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Treatment of chronic hepatitis C in young children cost effective. PharmacoEcon Outcomes News 862, 28 (2020). https://doi.org/10.1007/s40274-020-7146-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7146-1

Navigation